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Mycoplasmas as minimal, 
successful pathogens
Bacteria of the Class Mollicutes have often been 
portrayed as the simplest self-replicative life form 
because of their minute cell size, their total lack of 
a cell wall, the paucity of their metabolic pathways 
and their reduced genome. These features best 
describe the Mollicutes of the Mycoplasmataceae 
family, which contains one of the smallest free-liv-
ing organisms, Mycoplasma genitalium the genome 
of which barely contains 500 protein-coding genes 
[1]. Further subdivided into the Mycoplasma and 
Ureaplasma genuses, this family encompasses the 
vast majority of animal and human species of the 
Mollicutes, with more than 100 well-described spe-
cies [2–4]. Several of these are of particular concern 
for the medical and for the veterinary fields. In 
this review, the term ‘Mycoplasma’, which usually 
refers to Mollicutes, will be restricted to designate 
members of the Mycoplasmataceae family. 
A large number of Mycoplasma species are suc-
cessful pathogens of humans and a wide range 
of animals (TABLE 1) in which they often cause 
chronic infections that result in morbid rather 
than mortal diseases. These simple bacteria have 
adopted a parasitic lifestyle and live in close 
contact to the host, with a predilection for the 
mucosal surfaces of the respiratory and genital 
tracts. While current advances in molecular biol-
ogy, genomics and proteomics continue to take 
advantage of their reduced genome to under-
stand broad biological concepts, factors involved 
in mycoplasma-host colonization, virulence and 
pathogenesis remain largely unknown. 
Like many other parasites, mycoplasmas are 
faced with challenging, complex host environ-
ments to which they have to adapt and survive. 
More classical bacteria have evolved several mech-
anisms to cope and adjust to changing and hostile 
surroundings, one of which is based on classical 
gene regulation where changes in phenotypes 
are driven by gene activation/repression with 
feedback loops [5,6]. A drawback of this strategy 
is that it relies on a repertoire of specific sensing 
mechanisms that might not be suited to respond 
to new, challenging threats or conditions. These 
systems usually involve a cascade of events and 
consequently a number of regulatory and sens-
ing genes that are costly for the organisms, and 
appear to be lacking in the mycoplasma reduced 
genomes. Another strategy is to generate popu-
lation diversity through high-frequency, random 
mutation so that at least one variant may survive in 
a particular context [7,8]. Here, the main drawback 
would be the need for advanced maintenance and 
repair systems to prevent deleterious mutations in 
essential genes, and once again, these processes 
are limited in mycoplasmas. An alternative that 
has been adopted by these reduced bacteria is 
to couple particular gene subsets with rapid and 
reversible genetic changes that would produce a 
large number of cell-surface variants in an isogenic 
population. For this purpose, mycoplasmas have 
evolved a number of combinatorial genetic mecha-
nisms directed towards phase and size variation of 
major surface components so that when faced with 
unpredicted challenges, one variant may prevail. 
In the absence of a cell wall, the surface of 
the mycoplasma membrane constitutes a critical 
interface in the infectious process, mediating 
basic functions such as the transport of nutri-
ents as well as more complex interactions with 
the host cells and the host immune defenses. 
Therefore, understanding how and when phase 
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and antigenic variations occur at this particular 
location can provide valuable insights into the 
population dynamics and the strategies used by 
mycoplasmas to establish successful infections. 
In this review, the genetic systems involv-
ing related, large gene families and underlying 
high-frequency surface variation in mycoplas-
mas will be described and discussed in the con-
text of their biological significance during the 
infectious process. 
Mechanisms governing phase 
& antigenic variation of surface proteins
Mycoplasmas possess a number of sophisticated 
systems [9–12] that associate gene families of 
related, surface lipoproteins with a genetic mech-
anism that drives surface variation with a high 
frequency. So far, two types of ON/OFF molecu-
lar switches have been described that affect the 
expression status of particular genes and are either 
based on spontaneous mutations in regions prone 
to DNA slippage by nucleotide insertion/deletion 
in simple sequence repeats (homo- or heteropoly-
meric nucleotide tracts or short tandem repeats), 
or on DNA rearrangements involving site-specific 
recombinase. A third mechanism involves unidi-
rectional (gene conversion) or reciprocal recom-
bination and has a similar impact, although it 
affects the structure of a particular gene rather 
than its expression per se (FIGURE 1 & TABLE 2). 
Molecular switches involving DNA slippage 
(FIGURE 1A) were first described in the swine path-
ogen Mycoplasma hyorhinis [13,14]. This species 
possesses a genetic system composed of three 
to eight genes that are clustered on the chro-
mosome and encode related lipoproteins abun-
dantly expressed at the cell surface, namely the 
Vlps [15–17]. Each vlp gene represents a single 
transcription unit that contains a polyA tract 
lying in the promoter region between the -35 
and the -10 sequences. When the polyA tract is 
17 bp long, the downstream vlp is transcribed 
and translated. Insertion or deletion of a single 
nucleotide is sufficient to abolish vlp transcrip-
tion, most likely because of the critical contribu-
tion of the polyA tract to intrinsic local DNA 
curvature and to transcription initiation [14]. 
Overall, this genetic system offers an efficient 
ON/OFF switch that operates independently 
for each vlp gene in a noncoordinated man-
ner and results in Vlp oscillation in expression 
within propagating populations, with one cell 
expressing a single or a combination of any Vlp 
product [18]. A similar system is present in the 
avian pathogen Mycoplasma gallisepticum: the 
vlhA gene family that comprises approximately 
40 related lipoprotein genes distributed within 
several clusters [19–21]. Phase variation in VlhA 
expression is also governed at the transcription 
level, although mutations occur in a trinucle-
otide repeat (GAA), located at the 5´  end of the 
promoter of individual vlhA genes, upstream of 
the -35 box. When 12 GAA repeats are present, 
transcription of the downstream vlhA is allowed 
but the mechanism by which this element con-
trols transcription is not clear. Unlike for the 
Vlp system, data obtained so far suggest that an 
unknown mechanism prevents the expression of 
more than one vlhA gene in a given cell [20,22–24].
The second type of molecular switch asso-
ciated with phase variation in mycoplasmas 
is based on DNA rearrangements (FIGURE 1B). 
Several genetic systems have been described 
(TABLE 2) that use a cut-and-paste mechanism, 
Table 1. General features of major pathogenic mycoplasma species in which the occurrence of phase variable 
gene family has been described.
Mycoplasma species Phylogenetic group Host tropism Disease/pathology Genome accession 
number
M. capricolum subsp. 
capricolum 
Spiroplasma  
(Mycoides cluster)
Small ruminants Contagious agalactia NC_007633
M. hominis Hominis Human Opportunistic, urogenital tract NC_013511
M. hyorhinis Hominis Swine Respiratory disease, arthritis NA
M. synoviae Hominis Avian Respiratory disease, arthritis NC_007294
M. pulmonis Hominis Rodent Respiratory disease NC_002771
M. agalactiae Hominis Small ruminants Contagious agalactia NC_009497
M. bovis Hominis Large ruminants Respiratory disease, arthritis, mastitis NA
Ureaplasma parvum Pneumoniae Human Urogenital infections NC_002162
M. penetrans Pneumoniae Human Unknown (AIDS-associated) NC_004432
M. genitalium Pneumoniae Human Genital infections NC_000908
M. gallisepticum Pneumoniae Avian Respiratory disease NC_004829
NA: Not applicable.
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Figure 1. Main genetic mechanisms governing high-frequency phase- and antigenic-
variation of mycoplasma surface proteins. (A) ON/OFF switching by DNA slippage using 
Mycoplasma hyorhinis vlp genes as an example. Spontaneous, high-frequency mutations occur in the 
polyA tract located between the -35 and the -10 promoter region of each vlp gene. Transcription of 
any vlp gene only takes place when the polyA is 17 nt long. (B) ON–OFF switching by site-specific 
recombination using the situation encountered in the vpma system of Mycoplasma agalactiae (top) or 
the mpl system of Mycoplasma penetrans. In each system, a recombinase recognizes specific sites 
and catalyzes DNA rearrangements. (C) Antigenic variations by unidirectional recombinations (gene 
conversion), as occur in Mycoplasma synoviae in between an expressed locus and reservoir sequences 
located in relatively closed clusters. (D) Antigenic variations by reciprocal recombinations, as occur in 
Mycoplasma genitalium in between an expressed locus and archived donor sequences distributed all 
over the chromosome. Large arrows represent gene coding sequences; black arrow heads represent 
promoters except in (A) where promoters are detailed; dotted lines indicate DNA inversion.
†Short sequences targeted by the recombinase.
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involving a site-specific recombinase to alter-
nate silent structural genes behind a functional 
promoter. The vsp, the vsa and the vpma sys-
tems of M. bovis, Mycoplasma pulmonis and 
Mycoplasma agalactiae, respectively, all include 
clusters of variable genes in which a single gene is 
placed behind a promoter and is expressed while 
the others are silent [10,25–30]. All these systems 
possess a site-specific recombinase that recog-
nizes a specific short DNA sequence located 
upstream of each variable gene as a target for 
DNA rearrangements. Indeed, phase-locking of 
Vpma expression in the M. agalactiae type strain 
was achieved by disrupting the xer1 recombi-
nase gene located next to the vpma locus [31]. 
In M. agalactiae, the number of different Vpma 
products that can be expressed by any given cell 
is directly linked to its gene repertoire and, more 
specifically, to the number of variable gene clus-
ters. For instance, the M. agalactiae type strain 
that contains a single cluster of six vpma genes [32] 
can only express one vpma per cell and a total of 
six vpma combinations. By contrast, any given 
cell of the strain 5632 can express two Vpmas 
and at least 91 Vpma combinations because it 
possesses 23 vpma genes distributed into two 
separate clusters, each containing a functional 
xer1 gene [33]. Concomitant expression of vari-
able surface proteins also occurs in the human 
pathogen Mycoplasma penetrans, which possesses 
a family of immunodominant lipoproteins [34] 
encoded by 38 mpl genes distributed in three 
clusters [35]. Unlike the previous situation 
encountered in M. agalactiae, each mpl gene is 
equipped with its own invertible promoter [36]. 
ON/OFF switching in expression of each mpl 
gene is driven by flipping of its promoter and 
one additional difference with the M. agalactiae 
system resides in the location of the recombinase 
mediating these events, which was found 40 kb 
away from the nearer mpl gene cluster [37]. 
A third type of genetic mechanisms (FIGURE 1C) 
has been described more recently and involves 
high-frequency unidirectional (gene conversion) 
or reciprocal gene recombination for generating 
antigenic variation in Mycoplasma synoviae [38] 
and in M. genitalium [39,40], respectively. The vlhA 
family of M. synoviae is composed of a single vlhA 
gene, homolog to the vlhA genes of M. gallisepti-
cum (see above) and of several vlhA pseudogenes 
that lack 5´  end coding sequences. Extensive anti-
genic variation of the M. synoviae VlhA product is 
the result of unidirectional recombination events 
occurring between the entire functional vlhA 
copy and the pseudogenes, with duplication of the 
pseudogene sequence and loss of the correspond-
ing region in the previously expressed gene [38,41]. 
Unlike M. gallisepticum, in which the vlhA genes 
are distributed in several loci around the chromo-
some, the expressed vlhA gene and pseudogenes 
Table 2. Main mechanisms governing phase- and antigenic-variation of mycoplasma surfaces.
Type of variation Genetic event Mycoplasma species (gene family) Ref.
ON/OFF switching DNA slippage involving SSR in promoter regions M. hyorhinis (vlp) [13,14]
M. gallisepticum (vlhA)† [19,20]
M. capricolum subsp. capricolum (vmc) [55]
Site-specific recombination (gene rearrangement) M. pulmonis (vsa) [27,28]
M. bovis (vsp) [25,26]
M. agalactiae (vpma)‡ [29,31,62]
Ureaplasma parvum (mba) [63]
Site-specific recombination (promoter inversion) M. penetrans (mpl) [34,36,37]
Size variation DNA slippage involving short direct repeats within CDSs M. agalactiae (vpma) [33]
M. hyorhinis (vlp) [13,17,48]
M. pulmonis (vsa) [64]
M. bovis (vsp) [65]
Ureaplasma urealyticum (mba) [66]
Domain shuffling Gene conversion (unidirectional) M. synoviae (vlhA) [38]
Reciprocal recombination M. genitalium (mgp) [39,40]
DNA recombination§ M. agalactiae (vpma) [33]
M. bovis (vsp) [67]
Other Gene or locus duplication§ M. agalactiae (vpma) [33]
†The vlhA gene family was previously designated as pMGA.
‡Some of the vpma genes were also designated as avg [68].
§Expected to occur at low frequency (rare events).
CDS: Coding sequence; SSR: Single sequence repeat.
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are confined to a 114 kb region suggesting that in 
this system a relative proximity may facilitate site-
specific recombinations [42]. The strategy used by 
the human pathogen M. genitalium for generating 
antigenic diversity is also based on recombination. 
The genome of this mycoplasma species contains 
multiple repeats of sequences termed MgPar that 
have homology to mgpB and mgpC, two genes 
coding immunogenic adhesion proteins. This 
system is so far unique among bacteria in that 
it generates high-frequency antigenic variation 
via reciprocal recombinations between the mgpB 
and mgpC genes and the pool of MgPar archived 
donor sequences [39,40]. Unlike the situation 
encountered in M. synoviae, the MgPar sequences 
are arranged in several clusters dispersed on the 
chromosome. Whether differences in variable 
gene organizations in the two mycoplasma spe-
cies reflect two distinct genetic mechanisms for 
unidirectional and reciprocal recombinations is 
as yet unknown. 
Extent of the genetic events contributing 
to mycoplasma surface variation
The majority of the highly variable components 
described in mycoplasmas are surface exposed, 
encoded by multigene families and strongly rec-
ognized by the host humoral immune response [10]. 
All contain a signal peptide followed by a lipobox 
at their N-terminal while the rest of the molecule is 
made of blocks of amino acids that can be directly 
repeated or shared by other members of the family. 
These structural features are illustrated by the 
Vpma family of M. agalactiae, for which three 
strain repertoires have been fully sequenced and 
account for 18 distinct vpma genes recorded in 
this species (FIGURE 2) [29,33,43]. The primary amino 
acid sequence of the mature Vpma products is 
suggestive of several types of genetic events that 
contribute to generate diversity, in addition to 
phase variation. One of these events is the expan-
sion and contraction of the C-terminal sequence, 
possibly via a DNA slippage mechanism involving 
short direct repeats as illustrated by the allelic ver-
sion of VpmaD (Vpma-D1 and -D2) or VpmaF 
(VpmaF1 and F2). This genetic event results in 
size variation of particular variable products and 
has also been reported to occur with a number of 
other mycoplasma variable systems such as for the 
Vlp of M. hyorhinis, the Vsa of M. pulmonis and 
the Vsp of M. bovis. For M. agalactiae, the fre-
quency of this event is not known, but in M. hyo-
rhinis the occurrence of size variants of individual 
Vlp in clonal populations is high [18]. Another 
possible variation that may affect Vpma structure 
is the shuffling of a number of motifs, most likely 
by homologous recombination as suggested by 
comparing the primary amino acid sequences of 
VpmaU with VpmaZ and VpmaV. A third genetic 
event contributing to surface diversity is gene 
duplication followed by antigenic drift resulting 
in the emergence of allelic versions and new prod-
ucts. For instance VpmaD1, VpmaD2 and VpmaI 
are likely to be the products of duplication events 
followed by mutational events that have resulted 
in size variants of the same gene (Vpma D1 and 
VpmaD2) and of an allelic version (VpmaI). 
Intrastrain differences in the size of variable 
gene repertoires have been observed for most 
mycoplasma systems and generate an additional 
level of diversity. In M. agalactiae strain 5632, 
duplication of seven vpma genes at a second 
locus was responsible for a dramatic increase in 
surface diversification with 91 possible Vpma 
combinations compared with only six in the 
type strain, which only possesses a single six-
vpma gene cluster [33]. Contraction and expan-
sion of the variable gene repertoires are expected 
to be rare events and responsible for intrastrain 
diversity rather than intraclonal variation. 
However, as shown for M. agalactiae, these 
events may have a drastic impact on the pos-
sible antigenic mosaics displayed at the surface 
by one species.
All these events are superimposed to phase 
variation of the individual products and result 
in generating a highly dynamic repertoire of 
major immunodominant surface proteins. 
Phase and size variations have been shown to 
spontaneously occur in vivo and in vitro with 
a high frequency (10-2 to 10-5 events/cell/gen-
eration, in vitro) and to be reversible with the 
same frequency so that populations resulting 
from the expansion of a single cell are never 
pure (FIGURE 3A). This phenomenon is best illus-
trated by colony blotting using specific antibod-
ies directed towards a variable surface protein, 
which shows the occurrence of multiple sectors 
as the outcome of ON and OFF switching in 
expression of the targeted epitope (FIGURE 3B). 
Overall, the capacity of mycoplasmas to 
produce a large number of surface antigenic 
mosaics results from the association between 
contingency genes and multiple genetic events 
(e.g., ON–OFF switches, size variation, struc-
tural variation, and more rarely, gene duplica-
tion, gene loss) that occur in a noncoordinated, 
combinatorial manner (FIGURE 4). For most sys-
tems described in this review, the number of 
possible variants that can be generated by one 
particular system is difficult to assess but is 
expected to be remarkably high. For instance, 
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with approximately 40–70 vlhA pseudogenes 
identified in M. synoviae, the diversity gener-
ated by this pathogen has been estimated to 
exceed 105 VlhA variants [44]. In addition, M. 
genitalium, with 4% of its genome composed of 
MgPar reapeated sequences, is thought to gen-
erate an almost unlimited number of variants 
despite its minimized genome [40]. 
Biological significance of mycoplasma 
surface variations 
After processing of the signal peptide and mem-
brane anchorage via the lipid moiety, mature, 
phase–variable products are totally exposed at 
the mycoplasma cell surface and, in absence of a 
cell wall, are in close contact to the host environ-
ment. Interestingly, high-frequency phase and size 
VpmaA5632
VpmaB5632
VpmaI5632
VpmaVPG2
VpmaYPG2
VpmaF15632
VpmaF25632
VpmaXPG2
VpmaX5632
VpmaC5632
VpmaE5632
VpmaJ5632
VpmaK5632
VpmaUPG2
VpmaG5632
VpmaH5632
VpmaWPG2
VpmaW5632
VpmaL5632
VpmaD25632
VpmaD15632 ×18
VpmaZPG2
AvgF627
AvgC627
AvgB627
AvgE627
AvgA627
VpmaD
VpmaY
VpmaF
VpmaX
VpmaV
AvgD627
VpmaZ
VpmaW
Figure 2. Mosaic structures of the Vpma variable products in Mycoplasma agalactiae. Mature 
Vpma sequences (not including the signal sequence) are shown as long rectangles, with a same color 
representing highly similar blocks of amino-acids that are either repeated within one Vpma or shared 
by other Vpmas, while hatched regions correspond to unique sequences. The vpma repertoire of 
M. agalactiae has been sequenced in three strains (PG2, 5632 and an isolate, namely isolate 627 [43], 
in which vpma were designated avg) and is composed of 28 vpma genes that differ by at least one 
nucleotide. The primary amino acid sequences of the corresponding products revealed only 18 Vpma 
products, with allelic versions occurring in one (Vpma D, I and F), two (VpamY and V) or three 
(VmpaX, Z and W) strains.
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variation of surface components have only been 
described in Mollicutes that colonize immunocom-
pentent hosts (Mycoplasma and Ureaplasma), and 
have yet to be reported in those infecting plants 
or insects (Spiroplasma and Phytoplasma species). 
This observation is not surprising taking into 
account that antigenic variation is an old theme 
in the field of infectious diseases [8,45] and it is 
assumed that this phenomenon largely contributes 
to escaping the host immune response.
Although some species have been shown to 
establish facultative intracellular residence 
[46,47], mycoplasmas have to multiply and dis-
seminate in the extracellular compartment of 
their host and must withstand recognition by 
the host immune response. More specifically, in 
the absence of a cell wall, their cell surface must 
avoid antibody recognition that may interfere 
with essential membrane-associated functions. 
The importance of antigenic variation in pro-
viding mycoplasmas with a means of escaping 
host antibody damage was first supported by 
experimental evidence from M. hyorhinis [48]. 
Serum antibodies collected from an infected 
swine were shown to inhibit the growth of 
M. hyorhinis clonal variants expressing a short 
Vlp while those displaying long versions of 
the same Vlp were resistant. This behavior 
Multiplication
Selection
Variant 1
Multiplication
Selection
Variant 2
xer1
xer1
+
-
-
+
Figure 3. High-frequency phase variation of surface-exposed proteins in isogenic 
mycoplasma populations. (A) The outcome of frequent DNA rearrangements in generating surface 
diversity in an isogenic population using the vpma system of Mycoplasma agalactiae as an example. 
These events are reversible with the same frequency so that a single clone, regardless of whether it 
has been selected by a particular condition, has the capacity to produce the full repertoire of possible 
variants during multiplication. (B) Colonies M. agalactiae immunostained with Vpma-specific 
antibodies followed by unspecific incubation in Ponceau Red. Mycoplasma cells reacting positively 
with the antibodies appear as purple while those stained by the Ponceau Red were not 
immunostained. Top pictures represent individual colonies displaying sectors as a result of Vpma 
high-frequency phase variation while those at the bottom represent colonies from two isogenic 
variants predominantly expressing a different Vpma.
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ON/OFF
switching
Size
variation
Domain
shuffling
Antigenic
drift
Figure 4. Antigenic variation in mycoplasmas. Major antigenic changes are reported to affect 
the mycoplasma surface. The wall-less mycoplasma surface is illustrated by a lipid bilayer in which 
surface-exposed proteins and lipoproteins are anchored via their transmembrane domain or their lipid 
moieties, respectively. At least four major processes have been shown to modulate mycoplasma 
surface architecture and antigenic structure. ON/OFF switching is responsible for major antigenic 
changes occurring at high frequency within mycoplasma clonal populations (10-2 to 10-5/cell/
generation). This type of variation relates to the stochastic expression of several lipoprotein genes. 
The modulation of lipoprotein C-terminal domains, leading to changes in protein length at the cell 
surface, is another common mechanism of antigenic variation in mycoplasmas. ON/OFF switching 
and size variation of surface lipoproteins are involved in a masking/unmasking processes modulating 
mycoplasma interactions with the host environment, as well as antibody binding to conserved 
surface-exposed structures. Additional mechanisms generating surface diversity in mycoplasmas 
include domain shuffling and antigenic drift. Domain shuffling is the outcome of DNA recombination 
events occurring within gene families, while antigenic drift results from cumulative changes in 
lipoprotein amino acid sequences. With the exception of the latter phenomenon, all these changes 
may occur with a high frequency.
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was independent of the presence of comple-
ment and of the type of the Vlp expressed by 
the mycoplasma. Further propagation of suscep-
tible variants in the presence of M. hyorhinis host 
antibodies resulted in the selection of resistant 
populations that express a long Vlp as a result of 
a mutation-selection process. Emergence of a Vlp 
resistant phenotype depends on the most favor-
able mutation pathway that would rapidly lead to 
expressing a long Vlp. Depending on the genetic 
background of the parent, this consists of select-
ing variants that have either turned on a silent, 
long vlp gene or expanded the number of repeated 
motifs of an expressed, short vlp to elongate its 
corresponding C-terminal product. Detailed 
analyses revealed that the Vlps are not the target 
of the inhibition and that long Vlps are likely to 
mask critical, as yet unknown, components. 
The influence of host antibodies on phase 
variable products remains to be investigated 
in many mycoplasma systems but a number 
of other studies point towards a general role of 
these sophisticated variable systems in avoidance 
of the host immune system. This was elegantly 
shown for the vsa gene family of the murine 
pathogen M. pulmonis in which phase variation 
is driven by site-specific DNA rearrangements 
[27,49]. More specifically, in vivo experiments 
using wild-type mice versus mice deficient in B 
and T cells (RAG-/-) indicate that the adaptive 
immune system exerts a selection pressure on 
Vsa profile shifting [49]. In addition, the tempo-
ral antigenic shifts of the M. genitalium mgpB 
and mgpC sequences observed in women with 
persistent infections are consistent with a succes-
sive selection of variants driven by host immune 
selection pressure [39]. 
Studies performed with M. pulmonis also point 
towards a role for Vsa size variation in several 
biological processes. More precisely, M. pulmonis 
variants displaying short Vsa, with a few tandem 
repeats composing their C-terminal end, adsorb 
to erythrocytes, form biofilms and are efficiently 
killed by complement while those with long Vsa 
do not [50–52]. Considering these data and the role 
played by Vlp size variation in protecting essential 
components located at the M. hyorhinis surface 
(above), a more encompassing function has been 
proposed for these variable systems [48,52]. In the 
absence of a cell wall, abundant related liporoteins, 
by varying in nature, size and composition, would 
provide a flexible shield that can rapidly change 
surface accessibility by masking and unmask-
ing other stable components, thereby altering 
the overall thickness of the surface architecture. 
In this generic view, hypervariable lipoprotein 
families would modulate the interactions between 
the mycoplasma surface and the host cell, and the 
host environment, via a series of stochastic varia-
tions and selection processes. In addition to their 
nonspecific roles in avoiding the host immune 
response and in modulating surface accessibility, 
highly variable surface proteins may have addi-
tional overlapping functions, as suggested for the 
Vsp of M. bovis, which are thought to participate 
in adhesion to the host cell [53]. However, whether 
specific Vsp profiles correlate with the mycoplas-
ma’s ability to colonize particular host niches is 
not known. 
Advances in genomics & the discovery 
of new additional, variable systems
Currently, approximately 30 mycoplasma genomes 
are available in public databases and many more 
are expected to be sequenced within the coming 
years. Whether in silico analyses will uncover new 
systems depends, in part, on what is currently 
known on the mechanisms of antigenic variation 
and on the gene targeted by these variations. 
For instance, in silico detection in mycoplasma 
genomes of homopolymeric nucleotide tracts at 
the 5´  end of genes encoding putative lipopro-
teins could contribute to the identification of new 
putative phase-variable systems. A recent com-
parative genomic and proteomic ana lysis of two 
M. agalactiae strains points towards a number of 
lipoproteins, whose expression might be subjected 
to phase variation via DNA slippage in intragenic 
simple sequence repeats  [54]. These analyses also 
identified a new gene family encoding a related, 
predicted lipoproteins, namely the drp genes, 
members of which are scattered on the chromo-
some and differently expressed by the two strains, 
although no clear ON/OFF switching mecha-
nism has been identified. Whether these surface 
proteins only participate in generating intrastrain 
diversity or whether they are truly undergoing 
high-frequency phase- or antigenic-variation in 
isogenic population remains to be addressed. 
Genome-based approaches have previously been 
successful in defining molecular players involved 
in phase- or antigenic-variation in mycoplasmas by 
allowing either the understanding of the intrinsic 
mechanism of a particular system or the discovery 
of novel phase-variable genes. For instance in M. 
penetrans, the expression of each mpl gene is driven 
by an invertible promoter (FIGURE 1). Scanning of 
the entire M. penetrans genome has identified 
two putative tyrosine site-specific recombinases, 
one of which was experimentally shown to cata-
lyze the specific promoter inversion [37]. Another 
example of the contribution of genomics towards 
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variable systems is the comparison between whole 
Mycoplasma capricolum subsp. capricolum and 
Mycoplasma mycoides subsp. mycoides Small 
Colony biotype that revealed phase variation 
in expression of a six-gene family encoding sur-
face lipoproteins in M. capricolum subsp. capri-
colum [55] when combined with proteomic data. 
Finally, a recent comparative genomic ana lysis 
performed with two M. agalactiae strains has 
identified an additional 12 variable vpma genes 
in this species [33]. 
The ability to discover new variable systems 
or mechanisms by mining mycoplasma genomes 
will increase as more variable systems and the 
underlying genetic switches are characterized in 
mycoplasmas and other bacteria. 
Conclusion 
A number of mycoplasma species are able to 
establish successful infection in a wide range of 
hosts and to cause diseases that are often chronic, 
even in the presence of a specific immune 
response. These persistent infections suggest that 
the interaction between these simple bacteria and 
their host is far more complex than first expected. 
Clues to their success in host colonization and 
survival may reside in the mycoplasma’s ability 
to rapidly alter the antigenic make up of their 
surface via a number of sophisticated genetic 
systems. These complex systems are based on 
stochastic events that affect the expression and 
the structure of a number of abundant surface 
lipoproteins so that variants spontaneously 
emerge in clonal populations at a rate of 10-2 to 
10-5 events/cell/generation. Several studies sug-
gest that this high surface variability is a key 
element of the strategy evolved by mycoplasma 
species for avoiding the host immune response. 
It is no coincidence that most vaccine trials 
against mycoplasmas have been disappointing 
and mycoplasma high-frequency antigenic vari-
ation is one major contributor to the complexity 
in implementing preventive control measures. 
With their reduced genome bound by a sin-
gle membrane, mycoplasmas represent some 
of the simplest autonomous life forms. The 
plasticity of their surface architecture might 
then be more than a means to circumvent the 
immune response and may constitute a global, 
stochastic modulator of surface accessibility by 
masking and unmasking constantly expressed 
components, some of which might be crucial 
for mycoplasma survival [48]. While dynamic, 
phenotypic alteration of the mycoplasma surface 
architecture may compensate the lack of regu-
latory system found in more classical bacteria, 
it may also cover and uncover molecules [56–58] 
that are engaged in close interaction with the 
host cell, such as cell adhesion. Phase- and size-
variable genes that do not belong to the family 
encoding surface proteins were not included in 
this review but several have been characterized 
and shown to participate in host interactions [59] 
and, presumably, in modulating environmental 
responses to nutrients [60]. From these various 
aspects, mycoplasma phase and antigenic surface 
variation has emerged in these minimal patho-
gens as a key contributor to the success of the 
infection process. 
Future perspective
All mechanisms known to generate phase varia-
tion in bacteria have been described to occur 
in mycoplasmas except for that involving DNA 
site-specific methylation. Genomic data indicate 
the presence of several DNA methylase genes in 
these organisms but whether changes in meth-
ylation occur as an ON/OFF switch mechanism 
remains to be investigated.
Ongoing discussions on the random nature 
of rapid phase, size and antigenic variations 
in bacteria all point toward the need for re-
examining these systems in their natural 
environments [45,61]. While under steady state 
conditions, a given variable system will gen-
erate variants at a constant rate, the question 
of whether its intrinsic mechanism can be 
modulated by environmental changes would 
be important to assess for mycoplasmas. 
Mycoplasma genetic systems dedicated to 
high-frequency antigenic variation and the host 
immune system have co-evolved side by side and 
one intriguing question is whether the immune 
response contributes to selecting the best-fitted 
mycoplasma variants, as one adverse outcome of 
this long-term relationship. 
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Executive summary
Mycoplasmas as minimal, successful pathogens
Mycoplasmas are often portrayed as the simplest self-replicative life form because of their minute cell size, their total lack of a cell wall, 
the paucity of their metabolic pathways and their reduced genome. 
Several mycoplasma species are successful pathogens of humans and animals in which they often cause persistent infections of the 
respiratory and genital tracts.
Mechanisms governing phase & antigenic variation of surface proteins
Mycoplasmas possess a number of sophisticated systems that associate gene families of related, surface lipoproteins with genetic 
mechanisms that randomly switch their expression ON or OFF (phase variation) and/or affect their structure with a high frequency.
Two types of ON/OFF molecular switches have been described and are either based on spontaneous mutations in regions prone to 
DNA slippage by nucleotides insertion/deletion in simple sequence repeats, or on DNA rearrangements involving site-specific 
recombinase via a cut-and-paste mechanism.
A third mechanism involves unidirectional (gene conversion) or reciprocal recombination and affects the structure of particular genes.
Extent of the genetic events contributing to mycoplasma surface variation
In addition to phase variation, other super-imposed, combinatorial genetic events independently contribute to produce in mycoplasma 
an almost unlimited number of surface antigenic mosaics (e.g., high-frequency size variation, domain shuffling, gene duplication 
followed by antigenic drift, gene loss).
Biological significance of mycoplasma surface variations 
In the absence of a cell wall, the mycoplasma’s ability to rapidly alter its surface antigen make-up has emerged as a key element for 
avoiding the host immune response and might be a major contributor to the difficulties in developing vaccines. 
The high variability of the mycoplasma surface might be more than a means to circumvent the immune response and may constitute a 
global, stochastic modulator of surface accessibility by masking and unmasking steadily expressed components, some of which might 
be crucial for mycoplasma–host interaction and survival. 
Advances in genomics & the discovery of new additional, variable systems
Currently, approximately 30 mycoplasma genomes are available and data mining has already been successful in discovering novel phase 
variable genes or underlying intrinsic mechanisms. 
The identifying of new variable genes and the underlying genetic switches will increase as more genome becomes available and as 
more variable systems are defined in other bacteria.
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